Rhonda Germany Ballintyn's most recent trade in Integra Lifesciences Holdings Corp was a trade of 2,896 Common Stock done . Disclosure was reported to the exchange on May 14, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Integra Lifesciences Holdi... | Rhonda Germany Ballintyn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 2,896 | 17,162 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Rhonda Germany Ballintyn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 1,060 | 14,266 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Rhonda Germany Ballintyn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2020 | 4,218 | 13,206 (0%) | 0% | 0 | Common Stock | |
Integra Lifesciences Holdi... | Rhonda Germany Ballintyn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2020 | 791 | 8,988 (0%) | 0% | 0 | Common Stock |